Korro Bio
KRRO
71 hedge funds and large institutions have $373M invested in Korro Bio in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 8 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 19
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
4% more funds holding
Funds holding: 68 → 71 (+3)
0.09% more ownership
Funds ownership: 1.07% → 1.15% (+0.09%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $382M → $373M (-$9.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$27.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.19M |
| 3 |
Neuberger Berman Group
New York
|
+$7.5M |
| 4 |
RI
RTW Investments
New York
|
+$6.44M |
| 5 |
PA
Perceptive Advisors
New York
|
+$4.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$1.78M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$1.61M |
| 3 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
-$1.5M |
| 4 |
Morgan Stanley
New York
|
-$1.48M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.4M |
KRRO Hedge Fund Activity: Q3 2020 in Review
71 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2020, worth a combined $373M — down 2.4% from $382M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new KRRO positions and 8 closed out — a net gain of 3 holders — while 27 added to existing stakes and 19 trimmed.
The largest buyer was Wasatch Advisors, adding an estimated $27.1M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $1.78M sold.
- 71 institutional investors held Korro Bio (KRRO) as of Q3 2020, up from 68 in Q2 2020.
- Funds reported $373M of Korro Bio stock for Q3 2020, down 2.4% quarter-over-quarter.
- 11 funds opened new Korro Bio positions in Q3 2020 and 8 closed out, a net change of +3 holders.
- The largest Korro Bio buyer in Q3 2020 was Wasatch Advisors, an estimated $27.1M added.
- The largest Korro Bio seller in Q3 2020 was Allianz Asset Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q3 2020.